Clinical Trial Update: Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating efficacy and safety of Octreotide capsules (MYCAPSSA) for acromegaly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• MYCAPSSA (OCTREOTIDE)

Snippet

Sponsor: Chiasma, Inc. | Conditions: Acromegaly | Phase 3 | Status: UNKNOWN | Results posted: 2020-10-19